1. Home
  2. CTSO vs BWEN Comparison

CTSO vs BWEN Comparison

Compare CTSO & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • BWEN
  • Stock Information
  • Founded
  • CTSO 1997
  • BWEN N/A
  • Country
  • CTSO United States
  • BWEN United States
  • Employees
  • CTSO N/A
  • BWEN N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • BWEN Industrial Machinery/Components
  • Sector
  • CTSO Health Care
  • BWEN Industrials
  • Exchange
  • CTSO Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • CTSO 58.6M
  • BWEN 49.1M
  • IPO Year
  • CTSO N/A
  • BWEN N/A
  • Fundamental
  • Price
  • CTSO $0.92
  • BWEN $2.29
  • Analyst Decision
  • CTSO Buy
  • BWEN Strong Buy
  • Analyst Count
  • CTSO 2
  • BWEN 1
  • Target Price
  • CTSO $5.50
  • BWEN $6.00
  • AVG Volume (30 Days)
  • CTSO 78.2K
  • BWEN 242.4K
  • Earning Date
  • CTSO 11-06-2025
  • BWEN 11-12-2025
  • Dividend Yield
  • CTSO N/A
  • BWEN N/A
  • EPS Growth
  • CTSO N/A
  • BWEN N/A
  • EPS
  • CTSO N/A
  • BWEN N/A
  • Revenue
  • CTSO $36,107,520.00
  • BWEN $145,141,000.00
  • Revenue This Year
  • CTSO $11.93
  • BWEN $8.75
  • Revenue Next Year
  • CTSO $21.22
  • BWEN $3.50
  • P/E Ratio
  • CTSO N/A
  • BWEN N/A
  • Revenue Growth
  • CTSO 20.18
  • BWEN N/A
  • 52 Week Low
  • CTSO $0.71
  • BWEN $1.41
  • 52 Week High
  • CTSO $1.61
  • BWEN $3.03
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 45.35
  • BWEN 56.47
  • Support Level
  • CTSO $0.90
  • BWEN $1.88
  • Resistance Level
  • CTSO $0.96
  • BWEN $2.24
  • Average True Range (ATR)
  • CTSO 0.05
  • BWEN 0.13
  • MACD
  • CTSO -0.00
  • BWEN 0.02
  • Stochastic Oscillator
  • CTSO 16.67
  • BWEN 86.67

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: